Unleashing the full potential of Hsp90 inhibitors as cancer therapeutics through simultaneous inactivation of Hsp90, Grp94, and TRAP1Hye‐Kyung Park, Byoung Heon Kang|Experimental & Molecular Medicine|2020Cited by 143
Combination treatment with doxorubicin and gamitrinib synergistically augments anticancer activity through enhanced activation of BimHye‐Kyung Park, Byoung Heon Kang|BMC Cancer|2014Cited by 60
Pseudohypoxic stabilization of HIF1α via cyclophilin D suppression promotes melanoma metastasisHye‐Kyung Park, Byoung Heon Kang|Signal Transduction and Targeted Therapy|2025Cited by 4